文献速递咽喉与嗓音

吡非尼酮对声带瘢痕潜在治疗作用的体外研究

Potential treatment for vocal fold scar with pirfenidone.
PubMed 文献 · Laryngoscope · 2017-11-24

该研究在体外用吡非尼酮处理雪貂瘢痕声带来源的成纤维细胞,发现其可显著降低I型胶原mRNA表达、显著增加TGF-β1和HAS2 mRNA表达、显著抑制胶原凝胶收缩,但对αSMA表达无显著影响;提示吡非尼酮对声带瘢痕成纤维细胞具有体外抗纤维化作用。

要点

  • 吡非尼酮显著降低瘢痕声带成纤维细胞I型胶原mRNA表达。
  • 吡非尼酮显著抑制瘢痕声带成纤维细胞的胶原凝胶收缩。
  • 吡非尼酮对αSMA表达无显著影响,可能通过抑制p-Smad2/3核转位发挥作用。

核心结论

  • 吡非尼酮在体外对雪貂瘢痕声带来源的成纤维细胞具有抗纤维化作用。

研究设计与样本

  • 前瞻性动物实验对照研究,瘢痕声带成纤维细胞和正常声带成纤维细胞各来自4只雪貂。

主要发现

  • 在10 ng/mL TGF-β1存在下,吡非尼酮处理48小时后显著降低I型胶原mRNA表达(P < .05)。
  • 吡非尼酮显著增加TGF-β1和HAS2 mRNA表达(P < .05)。
  • 吡非尼酮显著抑制胶原凝胶收缩(P < .05),但对αSMA表达无显著影响。
  • 吡非尼酮处理后细胞核内p-Smad2/3表达减弱,可能提示抑制其从细胞质向细胞核转位。

临床怎么用

  • 该体外结果提示吡非尼酮可能作为声带瘢痕的抗纤维化候选药物,但尚需进一步在体研究验证。

局限性

  • 研究为体外雪貂成纤维细胞实验,样本量小(每组N = 4),结论不能直接外推至临床。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: Pirfenidone (PFD) is a strong antifibrotic agent that has been clinically approved in Japan for idiopathic pulmonary fibrosis. We examined the antifibrotic effects of PFD on fibroblasts isolated from scarred vocal folds (VFs) of ferrets in vitro. STUDY DESIGN: Prospective animal experiments with controls. METHODS: Scar fibroblasts (SFs) were isolated from scarred VFs that had been electrocauterized 2 weeks before harvesting (N = 4). Normal fibroblasts (NFs) were isolated from intact VFs (N = 4). SFs and NFs were incubated in the presence of 10 ng/mL transforming growth factor β1 (TGF-β1), with or without PFD. After the 48-hour incubation, mRNA expression levels of α smooth muscle actin (αSMA), TGF-β1, collagen type I, and hyaluronan synthase 2 (HAS2) were examined by real-time polymerase chain reaction. Immunohistochemistry with anti-αSMA anti-collagen type I and phosphorylated Smad (p-Smad)2/3 antibodies in SFs with or without PFD was performed. SFs and NFs were cultured in collagen gel with or without PFD for 48 hours, and the extent of gel contraction was examined quantitatively. RESULTS: PFD treatment significantly (P < .05) decreased mRNA expression of collagen type I, significantly increased mRNA expression of TGF-β1 and HAS2, and significantly suppressed collagen gel contraction. However, it did not have a significant effect on the expression of αSMA. The expression of p-Smad2/3 in the nucleus was faded with PFD, possibly demonstrating the suppression of translocation of p-Smad2/3 from cytoplasm to nucleus with PFD. CONCLUSIONS: This is the first report to demonstrate the in vitro antifibrotic effects of PFD on fibroblasts isolated from scarred VFs of ferrets. LEVEL OF EVIDENCE: NA. Laryngoscope, 128:E171-E177, 2018.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Kodama H, Kumai Y, Nishimoto K, et al. Potential treatment for vocal fold scar with pirfenidone. Laryngoscope. 2017. PMID: 29171670. doi:10.1002/lary.26999

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。